{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:29:57Z","timestamp":1791430197709,"version":"4.3.3"},"reference-count":53,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["0364821"],"award-info":[{"award-number":["0364821"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["540\/17"],"award-info":[{"award-number":["540\/17"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cabakoff grant","award":["0365076"],"award-info":[{"award-number":["0365076"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Currently, effective options are needed to fight vancomycin-resistant Enterococcus faecalis (VRE). The present study shows that combinations of phage and vancomycin are highly efficient against VRE, despite being resistant to the antibiotic. Vancomycin-phage EFLK1 (anti-E. faecalis phage) synergy was assessed against VRE planktonic and biofilm cultures. The effect of the combined treatment on VRE biofilms was determined by evaluating the viable counts and biomass and then visualized using scanning electron microscopy (SEM). The cell wall peptidoglycan was stained after phage treatment, visualized by confocal microscopy and quantified by fluorescence activated cell sorting (FACS) analysis. The combined treatment was synergistically effective compared to treatment with phage or antibiotic alone, both in planktonic and biofilm cultures. Confocal microscopy and FACS analysis showed that fluorescence intensity of phage-treated bacteria increased eight-fold, suggesting a change in the peptidoglycan of the cell wall. Our results indicate that with combined treatment, VRE strains are not more problematic than sensitive strains and thus give hope in the continuous struggle against the current emergence of multidrug resistant pathogens.<\/jats:p>","DOI":"10.3390\/v11100954","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T04:46:06Z","timestamp":1571287566000},"page":"954","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin"],"prefix":"10.3390","volume":"11","author":[{"given":"Mor","family":"Shlezinger","sequence":"first","affiliation":[{"name":"Department of Prosthodontics, Hadassah School of Dental Medicine, Hebrew University, Jerusalem 91120, Israel"},{"name":"Faculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunit","family":"Coppenhagen-Glazer","sequence":"additional","affiliation":[{"name":"Faculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gelman","sequence":"additional","affiliation":[{"name":"Faculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurit","family":"Beyth","sequence":"additional","affiliation":[{"name":"Department of Prosthodontics, Hadassah School of Dental Medicine, Hebrew University, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9967-730X","authenticated-orcid":false,"given":"Ronen","family":"Hazan","sequence":"additional","affiliation":[{"name":"Faculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"ref_1","first-page":"1039","article-title":"Update on bacterial nosocomial infections","volume":"16","author":"Bereket","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cabiltes, I., Coghill, S., Bowe, S.J., and Athan, E. (2019). Enterococcal bacteraemia \u201cSilent but deadly\u201d: A population-based cohort study. Intern. Med. J.","DOI":"10.1111\/imj.14396"},{"key":"ref_3","unstructured":"Gilmore, M.S., Clewell, D.B., Ike, Y., and Shankar, N. (2014). Enterococcal Infection-Treatment and Antibiotic Resistance. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, Massachusetts Eye and Ear Infirmary."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1016\/S0002-9343(98)00354-4","article-title":"The threat of vancomycin resistance","volume":"106","author":"Perl","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3855\/jidc.6587","article-title":"Clinical and microbiological features of bacteremia caused by Enterococcus faecalis","volume":"9","author":"Ceci","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/MMBR.68.3.560-602.2004","article-title":"Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion","volume":"68","author":"Brussow","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00284-016-1166-x","article-title":"Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages","volume":"74","author":"Cisek","year":"2017","journal-title":"Curr. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ph8030559","article-title":"Ecology of anti-biofilm agents II: Bacteriophage exploitation and biocontrol of biofilm bacteria","volume":"8","author":"Abedon","year":"2015","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fmicb.2018.00326","article-title":"Defeating antibiotic-and phage-resistant Enterococcus faecalis using a phage cocktail in Vitro and in a clot model","volume":"9","author":"Khalifa","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-302x.2004.00166.x","article-title":"In vitro antimicrobial effect of bacteriophages on human dentin infected with Enterococcus faecalis ATCC 29212","volume":"19","author":"Paisano","year":"2004","journal-title":"Oral Microbiol. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Shlezinger, M., Friedman, M., Houri-Haddad, Y., Hazan, R., and Beyth, N. (2019). Phages in a thermoreversible sustained-release formulation targeting E. Faecalis in vitro and in vivo. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219599"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbiotec.2017.01.002","article-title":"The use of bacteriophages to biocontrol oral biofilms","volume":"250","author":"Szafranski","year":"2017","journal-title":"J. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14712598.2019.1651287","article-title":"The fall and rise of phage therapy in modern medicine","volume":"19","author":"Gorski","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/genomeA.01308-15","article-title":"Complete Genome Sequence of Enterococcus Bacteriophage EFLK1","volume":"3","author":"Khalifa","year":"2015","journal-title":"Genome Announc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ismej.2017.16","article-title":"Lysogeny in nature: Mechanisms, impact and ecology of temperate phages","volume":"11","author":"Hargreaves","year":"2017","journal-title":"ISME J."},{"key":"ref_18","first-page":"e000169","article-title":"The lytic Myoviridae of Enterobacteriaceae form tight recombining assemblages separated by discontinuities in genome average nucleotide identity and lateral gene flow","volume":"4","author":"Accetto","year":"2018","journal-title":"Microb. Genom."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nir-Paz, R., Gelman, D., Khouri, A., Sisson, B.M., Fackler, J., Alkalay-Oren, S., Khalifa, L., Rimon, A., Yerushalmy, O., and Bader, R. (2019). Successful treatment of antibiotic resistant poly-microbial bone infection with bacteriophages and antibiotics combination. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciz222"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138920110790725311","article-title":"Phage choice, isolation, and preparation for phage therapy","volume":"11","author":"Gill","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","article-title":"Evolutionary Rationale for Phages as Complements of Antibiotics","volume":"24","author":"Hochberg","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1461-0248.2008.01253.x","article-title":"Interactive and cumulative effects of multiple human stressors in marine systems","volume":"11","author":"Crain","year":"2008","journal-title":"Ecol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.resmic.2018.04.008","article-title":"Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model","volume":"169","author":"Gelman","year":"2018","journal-title":"Res. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Comeau, A.M., Tetart, F., Trojet, S.N., Prere, M.F., and Krisch, H.M. (2007). Phage-Antibiotic Synergy (PAS): Beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000799"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11274-009-9991-8","article-title":"Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055","volume":"25","author":"Bedi","year":"2009","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/AEM.02850-14","article-title":"Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): Antibiotics stimulate lytic phage activity","volume":"81","author":"Kamal","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(45)91422-X","article-title":"Combined action of penicillin and bacteriophage on staphylococci","volume":"246","author":"Himmelweit","year":"1945","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resmic.2012.08.008","article-title":"Phage-antibiotic synergism: A possible approach to combatting pseudomonas aeruginosa","volume":"164","author":"Knezevic","year":"2013","journal-title":"Res. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Akturk, E., Oliveira, H., Santos, S.B., Costa, S., Kuyumcu, S., Melo, L.D.R., and Azeredo, J. (2019). Synergistic action of phage and antibiotics: Parameters to enhance the killing efficacy against mono and dual-species biofilms. Antibiotics, 8.","DOI":"10.3390\/antibiotics8030103"},{"key":"ref_31","first-page":"703","article-title":"Synergistic interaction between phage therapy and antibiotics clears pseudomonas aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpb.2019.08.004","article-title":"Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections","volume":"142","author":"Lin","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.33.9.1588","article-title":"In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis","volume":"33","author":"Sahm","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1126\/science.1080613","article-title":"Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis","volume":"299","author":"Paulsen","year":"2003","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AEM.00096-15","article-title":"Targeting Enterococcus faecalis biofilms with phage therapy","volume":"81","author":"Khalifa","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-7012(00)00122-6","article-title":"A modified microtiter-plate test for quantification of staphylococcal biofilm formation","volume":"40","author":"Stepanovic","year":"2000","journal-title":"J. Microbiol. Methods"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1574-6968.2011.02445.x","article-title":"Listeria monocytogenes tyrosine phosphatases affect wall teichoic acid composition and phage resistance","volume":"326","author":"Eugster","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2174\/1568026616666160930145649","article-title":"Phage Therapy: A new horizon in the antibacterial treatment of oral pathogens","volume":"17","author":"Shlezinger","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_39","first-page":"269","article-title":"Treatment of dysentery in children with polymyxin and bacteriophage","volume":"9","author":"Sheviakova","year":"1964","journal-title":"Antibiotiki"},{"key":"ref_40","first-page":"40","article-title":"Effect of bacteriophage on resistance of flexner\u2019s bacillus to antibiotics","volume":"1","author":"Sheviakova","year":"1956","journal-title":"Antibiotiki (Mosc)"},{"key":"ref_41","first-page":"96","article-title":"Effect of combined antibiotics of the tetracycline series with bacteriophage on Shigella dysenteriae","volume":"3","author":"Sheviakova","year":"1958","journal-title":"Antibiotiki (Mosc)"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/jctb.438","article-title":"Phages and their application against drug-resistant bacteria","volume":"76","author":"Chanishvili","year":"2001","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-394621-8.00016-9","article-title":"Phage lambda\u2014New insights into regulatory circuits","volume":"82","author":"Wegrzyn","year":"2012","journal-title":"Adv. Virus Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/ps\/83.12.1944","article-title":"Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers","volume":"83","author":"Huff","year":"2004","journal-title":"Poult. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/mdr.2006.12.164","article-title":"Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage","volume":"12","author":"Hagens","year":"2006","journal-title":"Microb. Drug Resist."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fmicb.2017.00837","article-title":"The bacteriophage ef-p29 efficiently protects against lethal vancomycin-resistant Enterococcus faecalis and alleviates gut microbiota imbalance in a murine bacteremia model","volume":"8","author":"Cheng","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/mBio.01304-16","article-title":"Molecular basis for lytic bacteriophage resistance in enterococci","volume":"7","author":"Duerkop","year":"2016","journal-title":"MBio"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e24872","DOI":"10.4161\/bact.24872","article-title":"What are the limitations on the wider therapeutic use of phage?","volume":"3","author":"Henein","year":"2013","journal-title":"Bacteriophage"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ajcp\/aqw131","article-title":"Laboratory investigation of Myeloproliferative Neoplasms (MPNs): Recommendations of the Canadian Mpn Group","volume":"146","author":"Busque","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF01967563","article-title":"Structure, biochemistry and mechanism of action of glycopeptide antibiotics","volume":"8","author":"Reynolds","year":"1989","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1086\/321815","article-title":"Vancomycin-resistant enterococci: Mechanisms and clinical observations","volume":"33","author":"Gold","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0966-842X(00)01705-4","article-title":"Phages will out: Strategies of host cell lysis","volume":"8","author":"Young","year":"2000","journal-title":"Trends Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s00253-017-8224-6","article-title":"Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process","volume":"101","author":"Latka","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/10\/954\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:26:59Z","timestamp":1760189219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/10\/954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["v11100954"],"URL":"https:\/\/doi.org\/10.3390\/v11100954","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]}}}